|
UXS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.630200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.538000E-03 |
| Normal-vs-Stage2 |
5.595300E-03 |
| Normal-vs-Stage3 |
1.897590E-02 |
| Normal-vs-Stage4 |
1.678160E-01 |
| Stage1-vs-Stage2 |
2.188800E-01 |
| Stage1-vs-Stage3 |
8.711200E-01 |
| Stage1-vs-Stage4 |
3.109600E-01 |
| Stage2-vs-Stage3 |
1.926390E-01 |
| Stage2-vs-Stage4 |
7.406300E-02 |
| Stage3-vs-Stage4 |
3.991000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.783900E-03 |
| Normal-vs-AfricanAmerican |
1.115890E-02 |
| Normal-vs-Asian |
1.349800E-02 |
| Caucasian-vs-AfricanAmerican |
1.893570E-01 |
| Caucasian-vs-Asian |
7.564200E-01 |
| AfricanAmerican-vs-Asian |
3.104800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.660000E-02 |
| Normal-vs-Female |
2.184400E-04 |
| Male-vs-Female |
1.429400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.138000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.298560E-03 |
| Normal-vs-Age(61-80Yrs) |
9.484900E-03 |
| Normal-vs-Age(81-100Yrs) |
6.479000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.720400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.996600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.550200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.217200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.438800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.689000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.64250000000066E-05 |
| Classical-VS-Follicular |
5.541400E-01 |
| Classical-VS-Other |
1.343190E-01 |
| Classical-VS-Normal |
6.11959999999856E-05 |
| Tall-VS-Follicular |
6.680900E-03 |
| Tall-VS-Other |
9.170200E-01 |
| Tall-VS-Normal |
6.607600E-01 |
| Follicular-VS-Other |
2.698000E-01 |
| Follicular-VS-Normal |
1.596000E-02 |
| Other-VS-Normal |
8.087800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.858870E-03 |
| Normal-vs-N1 |
9.513800E-01 |
| N0-vs-N1 |
7.483000E-03 |
|
|
